Featured Research

from universities, journals, and other organizations

Targeting Pancreatic Cancer

Date:
February 15, 2006
Source:
Cold Spring Harbor Laboratory
Summary:
In the March 1 issue, Drs. Johanna Joyce, Douglas Hanahan and colleagues lend new insight into how broad-spectrum cysteine cathepsin inhibitors combat pancreatic cancer, and provide new data to help refine the design of more precisely targeted anti-cathepsin therapies.

In the March 1 issue, Drs. Johanna Joyce (MSKCC), Douglas Hanahan (UCSF) and colleagues lend new insight into how broad-spectrum cysteine cathepsin inhibitors combat pancreatic cancer, and provide new data to help refine the design of more precisely targeted anti-cathepsin therapies.

"These results may help guide the design of clinical trials aimed to assess cathepsin inhibitors as cancer therapies" said Dr. Joyce

Their paper will be made available online ahead of print at www.genesdev.org on 2/15.

In 2004, the research team found that pharmacological inhibition of all cysteine cathepsins effectively thwarted tumor progression in a mouse model of pancreatic islet cell cancer. In their current study, Dr. Joyce and colleagues provide mechanistic insight into the specific roles that individual cathepsins play in tumorigenesis, and why their inhibition suppresses cancer development.

To determine how the loss of individual cathepsin genes affects tumorigenesis, the researchers engineered the pancreatic cancer-prone mice to also lack one of four cathepsin genes: cathepsin B, C, L or S. They found that cathepsin B-, L-, or S-deficient transgenic mice displayed reduced tumor formation -- but cathepsin C-deficient mice did not. Dr. Joyce and colleagues were then able to identify the stage-specific roles of cathepsins B, L and S in tumor development, as well as a key downstream target that mediates the tumorigenic roles of these three cathepsins.

Dr. Joyce and colleagues found that E-cadherin (a known inhibitor of tumor invasion) is a target substrate of cathepsins B, L and S -- but not cathepsin C. Their evidence suggests that cathepsins B, L and S promote pancreatic tumor invasion by cleaving, and thereby inactivating, E-cadherin. Interestingly, the researchers also found elevated levels of cathepsins B and L in some human pancreatic tumor samples.

Dr. Joyce explains that "Using the powerful approach of mouse genetics, we have been able to identify distinct, stage-specific roles for members of the cysteine cathepsin family. These data should provide insight into both the stage in cancer development in which to target cathepsins, as well as the individual family members to target. Our functional studies in mice and our analysis of human pancreatic tumors suggest that a selective inhibitor of cathepsins B and L could have therapeutic value against invasive carcinomas."



Story Source:

The above story is based on materials provided by Cold Spring Harbor Laboratory. Note: Materials may be edited for content and length.


Cite This Page:

Cold Spring Harbor Laboratory. "Targeting Pancreatic Cancer." ScienceDaily. ScienceDaily, 15 February 2006. <www.sciencedaily.com/releases/2006/02/060215230426.htm>.
Cold Spring Harbor Laboratory. (2006, February 15). Targeting Pancreatic Cancer. ScienceDaily. Retrieved April 18, 2014 from www.sciencedaily.com/releases/2006/02/060215230426.htm
Cold Spring Harbor Laboratory. "Targeting Pancreatic Cancer." ScienceDaily. www.sciencedaily.com/releases/2006/02/060215230426.htm (accessed April 18, 2014).

Share This



More Health & Medicine News

Friday, April 18, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

'Holy Grail' Of Weight Loss? New Find Could Be It

'Holy Grail' Of Weight Loss? New Find Could Be It

Newsy (Apr. 18, 2014) In a potential breakthrough for future obesity treatments, scientists have used MRI scans to pinpoint brown fat in a living adult for the first time. Video provided by Newsy
Powered by NewsLook.com
Little Progress Made In Fighting Food Poisoning, CDC Says

Little Progress Made In Fighting Food Poisoning, CDC Says

Newsy (Apr. 18, 2014) A new report shows rates of two foodborne infections increased in the U.S. in recent years, while salmonella actually dropped 9 percent. Video provided by Newsy
Powered by NewsLook.com
Scientists Create Stem Cells From Adult Skin Cells

Scientists Create Stem Cells From Adult Skin Cells

Newsy (Apr. 17, 2014) The breakthrough could mean a cure for some serious diseases and even the possibility of human cloning, but it's all still a way off. Video provided by Newsy
Powered by NewsLook.com
Obama: 8 Million Healthcare Signups

Obama: 8 Million Healthcare Signups

AP (Apr. 17, 2014) President Barack Obama gave a briefing Thursday announcing 8 million people have signed up under the Affordable Care Act. He blasted continued Republican efforts to repeal the law. (April 17) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins